Company page

Genocea Biosciences Inc

Genocea Biosciences Inc, trading under the ticker GNCAQ, is a public company based in America with a market capitalization of approximately $58.78 million. The company focuses on developing innovative immunotherapies for cancer and infectious diseases. Genocea leverages its proprietary technology platform to advance its product candidates in the biopharmaceutical sector.